Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC

 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/26/2015 08/27/2015 08/28/2015 08/31/2015 09/01/2015 Date
0.51(c) 0.5201(c) 0.559(c) 0.56(c) 0.56 Last
218 510 37 424 113 913 92 826 45 835 Volume
-1.92% +1.98% +7.48% +0.18% 0.00% Change
More quotes
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company.It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
Sector
Biotechnology & Medical Research
Calendar
09/10 | 11:15amPresentation
More about the company
Latest news on CYCLACEL PHARMACEUTICALS I
08/12 CYCLACEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
08/12 CYCLACEL PHARMACEUTICALS : Reports Second Quarter 2015 Financial Results
08/12 CYCLACEL PHARMACEUTICALS : Reports Second Quarter 2015 Financial Results
08/11 CYCLACEL PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
08/11 Cyclacel Pharmaceuticals Reports Second Quarter 2015 Financial Results
08/06 CYCLACEL PHARMACEUTICALS : to Release Second Quarter 2015 Financial Results
08/06 CYCLACEL PHARMACEUTICALS : to Release Second Quarter 2015 Financial Results
08/05 CYCLACEL PHARMACEUTICALS : Notice of Delisting or Failure to Satisfy a Continued..
More news
Sector news : Bio Therapeutic Drugs
08:01a INCYTE : to Present at Upcoming Investor Conferences
08/31 GENMAB A/S : Total Number of Voting Rights and Total Share Capital
08/31 MEDICINES : shares surge on upbeat cholesterol drug study
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08:00a BIOTECH WEEKLY : Reviewing The <1x Book Biotech Screen
08/12 Cyclacel Pharma net loss improves in Q2
08/11 Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q2 2015 Results - Earn..
08/11 Cyclacel Pharmaceuticals reports Q2 results
05/13 Cyclacel Pharma revenues up 25% in Q1


Comments 
Advertisement
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Technical analysis trends CYCLACEL PHARMACE...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials